Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is this a little of the pot calling the kettle black?
" Companies trying to unseat Google Inc. from the lead position in the bidding on Nortel Networks Corp.'s patent portfolio have until 4 p.m. Eastern time Monday to take a shot at it. The list of contenders likely will include Microsoft Corp. Apple Inc., Research in Motion Ltd., and perhaps Telefon AB L.M. Ericsson of Sweden, Intel Corp. and China's ZTE Corp.
Francisco Caceres
"We hope and plan for a vibrant auction that will be attended by people world-wide," said Lisa Schweitzer of Cleary Gottlieb Steen & Hamilton, the law firm running Nortel's U.S. bankruptcy liquidation.
Apple, Research in Motion and Ericsson didn't respond to inquiries seeking confirmation they would join in the competition. LTE couldn't be reached for comment, and Intel declined comment. Microsoft issued a statement that said, "Microsoft has a world-wide, perpetual, royalty-free license to all of Nortel's patents that covers all Microsoft products and services, resulting from the patent cross-license signed with Nortel in 2006."
Nortel, of Toronto, filed for insolvency protection around the world in January 2009, and began selling itself off in pieces six months later. This month, Nortel puts its last major asset, a collection of thousands of technology patents and patent applications, on the block after prolonged marketing.
Monday's 4 p.m. bid deadline can be pushed back, under the court-approved rules, if the company and the creditors who will be watching over Nortel's shoulder think it's justified.
Once the bid envelopes are opened, Nortel has time to decide who will actually kick off the bidding. Under the rules, Nortel is required to name the starting bid by high noon at least one day prior to the June 20 auction.
If past auctions are any guide, chances are the starting bid won't come from "stalking horse" Google. By definition, offers that come in Monday have to be higher and better, or at least as good as Google's $900 million proposition, or there won't be an auction at all.
Google's offer is likely just the opening move in a "chess game," said patent litigator and licensing adviser Michael Lennon, who is with Kenyon & Kenyon LLP. Private-equity investors could join bidding teams, as could patent licensing specialists like RPX Corp.
The prospect of picking up the wide-ranging, international portfolio of intellectual property will amp the intensely competitive technology players into "Wild West" mode, Mr. Lennon predicted. Nortel patents confer intellectual property rights over every major area of technology business, from wireless devices to Internet advertising, to voice-activated control packages to next-generation mobile data transmission to optical and data networking.
They are good for defensive uses, warding off infringement actions, as Google has said, and offensive uses, as well. They could also produce ready cash, through licensing.
Much as technology companies like to complain about having their innovations caught up in court fights, Mr. Lennon said, "They are all are asserting their intellectual property rights against each other all the time."
The sheer size of Nortel's portfolio expands the strategic options for buyers, said Robert Merges, a law professor at University of California-Berkeley's Boalt Hall School of Law and co-founder of the Berkeley Center for Law and Technology.
"The way this game is played, someone throws a stack of patents on the table, and someone else throws a stack on the table and the one with the shortest stack comes out on the losing end," Mr. Merges said.
Putting a price tag on individual patents isn't so tough, even in a litigious industry where a single claim of a single patent can mean hundreds of millions of dollars of damages, or tens of millions of dollars of legal costs. Mr. Lennon said appraisers can sit down and come up with an inherent commercial value for a patent "based on how much in damages a person could collect, analyzing profitability in the market of a product and how much is sold."
The final price for Nortel's collection of patents, however, is something that can perhaps only be determined by seeing what the market will bear, Mr. Lennon said.
"When you have a portfolio of this size, its potential to impact the markets that companies like Google or Apple are operating in, it's huge. It's almost unprecedented, almost impossible to put a value on it other than to put it up for auction. Like an Andy Warhol painting, it's not something you can put a number on in traditional ways," Mr. Lennon said."
Read more: http://online.wsj.com/article/SB10001424052702304778304576375832688371692.html#ixzz1ThIuMwHx
Canon agreement finalized
"Altair Nanotechnologies Closes Canon Investment Transaction
Altair Nanotechnologies Inc. (MM) (NASDAQ:ALTI)
Intraday Stock Chart
Today : Monday 25 July 2011
Altair Nanotechnologies Inc. (NASDAQ: ALTI) (Altairnano) today announced it had closed on a Share Subscription Agreement with Canon Investment Holdings Limited (Canon), through its affiliate, Energy Storage Technology (China) Group Limited (EST). Under the terms of the agreement, Altairnano issued 37,036,807 common shares to EST at $1.5528 per share, providing $57.5 million in proceeds to Altairnano. Following the closing of this transaction, there are 69,452,487 Altairnano common shares outstanding.
On September 20, 2010, Altairnano announced that it had entered into the Share Subscription Agreement, as amended, under which Canon had agreed to purchase newly issued common shares of Altairnano, which resulted in EST owning 53.3 percent of Altairnano's common shares, 49.8 percent on a fully diluted basis, immediately following the closing.
"While this transaction took considerably longer to close than expected, the Canon investment allows us to now focus on growing the business and creating shareholder wealth," said Terry Copeland, Altairnano president and Chief Executive Officer.
Canon chairman Wei Yincang added, "The investment in Altairnano represents an important milestone for both companies to significantly grow our businesses and accelerate the commercialization of the Altair lithium-titanate technology."
About Altair Nanotechnologies Inc.
Headquartered in Reno, Nev. with manufacturing in Anderson, Ind., Altairnano is a leading provider of energy storage systems for clean, efficient power and energy management. Altairnano's nano lithium-ion titanate-based solutions are among the highest performing and most scalable, with applications that include complete energy storage systems for frequency regulation and renewables integration for the electric grid, and battery modules and cells for transportation and industrial applications. For more information, visit www.altairnano.com.
About Canon Investment Holdings Limited
Headquartered in Zhuhai, China, Canon is the holding company of Yintong Energy Company Ltd, which is an advanced manufacturer of high-capacity and high-power lithium battery products. Yintong's batteries are used in a range of customer applications, including bus and energy storage solutions. For more information, please visit Yintong at www.ytenergy.com.cn.
Forward-Looking Statements"
The Canon agreement does not appear to be finalized to me
"Altair Nanotechnologies Inc. (NASDAQ: ALTI) today announced it has agreed to a fourth amendment to the Share Subscription Agreement (the "SSA") initially entered into with Canon Investment Holdings Limited ("Canon") on September 20, 2010 and subsequently amended on February 16, May 17 and June 3, 2011. This Fourth Amendment to the SSA extends the End Date to, and sets the Closing Date as, July 8, 2011 but keeps in place the ability of Altairnano to pursue other alternatives and to terminate the SSA at any time with no penalty. The SSA calls for Canon to acquire newly issued shares of the Company's common stock valued at $57.6 million resulting in a 51% ownership on a fully diluted basis immediately upon closing.
The company stated in both its May 17 and June 3, 2011 press releases on this transaction that it would continue working toward closing with Canon, but also thoroughly examine alternatives to the Canon deal.
"We will continue to remain open to completing the transaction with Canon," stated Terry Copeland, Altairnano's president and Chief Executive Officer. "At the same time, we are continuing discussions with other major energy providers and industrial companies and will thoroughly pursue these alternatives."
according to my calculations. Between the 17th and the 18th of May. Philip Frost bought 65,000 shares
large amount of insider buying:
LTS up 3.45% after Multiple insiders buy.
Multiple insiders of LADENBURG THALMANN FINANCIAL SERVICES INC (AMEX: LTS) bought Shares of LTS.
(EMAILWIRE.COM, May 19, 2011 ) Boston, MA - InsiderCow.com: Multiple insiders of LADENBURG THALMANN FINANCIAL SERVICES INC (AMEX: LTS) bought 55,000 shares of LTS from the open market on 2011-05-17 according to an SEC filing reported by insidercow.com at 2011-05-17 09:05:51 ET. The stock was up 3.45% after the InsiderCow.com report.
Trade amount: 55,000 Shares
Trade type: Open Market Buy
Price Range: $1.15-$1.19
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=LTS You can also get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.
About InsiderCow.com
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
About LTS:
Ladenburg Thalmann Financial Services Inc., through its subsidiaries, provides a range of financial services primarily to corporate and institutional clients, and high net-worth individuals in the United States.
Disclosure: Insidercow.com is not a registered investment advisers or broker/dealer. Insidercow.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.
CONTACT: InsiderCow.com
e-mail: support@insidercow.com
WWW: http://www.insidercow.com
update on Canon agreement:
"RENO, NV--(Marketwire - May 17, 2011) - Altair Nanotechnologies Inc. (NASDAQ: ALTI) today announced that it has entered into a Second Amendment to Share Subscription Agreement (the "Amendment") with Canon Investment Holdings Limited ("Canon") extending the agreed upon closing date under the Share Subscription Agreement with Canon (the "SSA") from May 17, 2011 to June 3, 2011. The SSA calls for Canon to acquire newly issued shares of the Company's common stock valued at $57.6 million resulting in a 51% ownership on a fully-diluted basis immediately upon closing."
Canon has stated that it needs additional time to finalize the necessary actions required for it to close this transaction. In addition to delaying the closing date, the parties agreed that, in the interim, Altair may investigate other potential strategic investments, and that if it should structure an alternative partnership, may terminate the SSA with no penalty and pursue the alternative.
"We believe that closing the SSA with Canon is in the best long-term interests of both parties and continue to cooperate with Canon and work toward closing on the revised date of June 3rd," said Terry Copeland Altair's president and CEO. "However, until such date, we need to be thoroughly examining alternatives and that is exactly what we intend to do."
About Altair Nanotechnologies Inc.
Headquartered in Reno, Nevada with manufacturing in Anderson, Indiana, Altairnano is a leading provider of energy storage systems for clean, efficient power and energy management. Altairnano's Lithium-Titanate based battery systems are among the highest performing and most scalable, with applications that include complete energy storage systems for use in providing frequency regulation and renewables integration for the electric grid, and battery modules and cells for transportation and industrial applications. For more information please visit Altairnano at www.altairnano.com.
Is this old news?
" O2 Secure Wireless, Inc. (Pink Sheets: OTOW) announces that the financials have been finalized and submitted to Pink Sheets. The updated status, as expected, has resulted in a Tier elevation.
"We are working diligently to get things in order for the projects, both domestic and abroad. We currently are in the negotiation stages with a variety of entities relating to both current projects as well as future projects. As these are completed we will update our shareholders. We are pleased to be able to announce that the financials have been submitted. As we've stated in quarters past, transparency is of the upmost importance to our Company. We want for our shareholders to know that we hold them in a very high regard, and intend to continue building on the value of their positions in our Company," stated Val Kazia, President, O2 Secure Wireless Inc.
The Company is currently in the Due Diligence process for funding through Ark Capital. An update will be announced as soon as we are able to make the details public.
About O2 Secure Wireless: O2 Secure Wireless is a Company that is currently developing numerous wireless tower facilities in the U.S. The Company is also instrumental in the development of wireless broadband communication services domestically. Under a recent merger with Earthcom Service Inc., the Company is currently being structured to provide affordable flat rate pre-paid wireless services in developing countries internationally.
Safe Harbor Act : This release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.
For more information visit our website at http://o2securewireles s .com or contact
Investor Relations: Gibraltan Financial (407)830-9777
SOURCE O2 Secure Wireless, Inc."
http://pr-usa.net/index.php?option=com_content&task=view&id=731094&Itemid=29
more upgrades:
"A pair of upbeat commentaries from analysts is sending shares of stem-cell company Pluristem Therapeutics Inc. higher premarket. Oppenheimer starts coverage with a stock-investment rating of outperform, noting upbeat study data. Pluristem is developing placenta-based stem-cell therapies which “can be administered to the patient immediately by the treating physician” instead of cell harvesting, processing and reinfusion. And Needham says Pluristem has enough cash to last it through 2013 and that it is “considering pharma partnerships…which may provide further capital infusion.” Pluristem, already up 79% this year amid the study data, adds another 11% to $2.85."
http://blogs.wsj.com/marketbeat/2011/05/17/stocks-to-watch-h-p-wal-mart-and-more/?mod=yahoo_hs
new upgrade
"May 17, 2011 (SmarTrend News Watch via COMTEX) -- Pluristem Therapeutics (NASDAQ:PSTI) initiated at Outperform at Oppenheimer... "
http://www.zacks.com/research/get_news.php?id=137l4869
from 10-Q
Item 1. Legal Proceedings
We have been or are involved in the following ongoing legal matters:
On November 18, 2009, we sued InfiniTek Corporation (“InfiniTek”) in the Texas State District Court in Fort Worth, Texas for breach of contract and other claims (the “Texas Action”) seeking equitable relief and unspecified damages when a dispute between the Company and InfiniTek was not resolved. All agreements with InfiniTek have been cancelled. On January 15, 2010, InfiniTek filed a counter-claim for non-payment of amounts billed. InfiniTek claims it is owed $195,000, and has incurred alleged lost opportunity cost of not less than $220,000. We attempted unsuccessfully to resolve our dispute with InfiniTek via mediation. Our lawsuit was amended on March 30, 2010. Discovery is ongoing.
On April 7, 2010, we were served with a lawsuit filed by InfiniTek in the California Superior Court in Riverside, California seeking damages in excess of $76,303 for breach of contract and lost profit. This lawsuit relates to one of the causes of action, and the same set of underlying facts, as those in the Texas legal action mentioned above. On May 7, 2010, we filed a motion to dismiss this action. On July 14, 2010, the court denied our motion. On August 13, 2010, we filed an answer to InfiniTek’s complaint, including a denial and affirmative defenses. We continue to litigate the claims made by InfiniTek in this action as well as our other claims against InfiniTek in the Texas case. The amounts in dispute are included in our accounts payable and accrued liabilities pending the outcome of this litigation.
On November 15, 2010, we filed a lawsuit in the Federal District Court for the Eastern District of Texas (the “Vertical Action”) against Interwoven, Inc. ("Interwoven"), LG Electronics MobileComm U.S.A., Inc., LG Electronics, Inc., Samsung Electronics Co., Ltd. and Samsung Electronics America, Inc. (collectively, the "Defendants"). We sued the Defendants for patent infringement claims under United States Patent No. 6,826,744 (“System and Method for Generating Web Sites in an Arbitrary Object Framework”) and United States Patent No. 7,716,629 (“System and Method for Generating Web Sites in an Arbitrary Object Framework”), both of which are owned by the Company. We seek an award of monetary damages and other relief. The case is styled Vertical Computer Systems, Inc. v Interwoven, Inc., LG Electronics Mobilecomm U.S.A., Inc., LG Electronics Inc., Samsung Electronics Co., Ltd., Samsung Electronics America, Inc., No. 2:10-CV-00490.
On November 17, 2010, we were served with a lawsuit filed on October 14, 2010 by Interwoven in the United States District Court for the Northern District of California (the “Interwoven Action”). This lawsuit is a complaint for declaratory judgment, in which Interwoven is requesting that the court find that no valid and enforceable claim of either of the two patents referenced above has been infringed by Interwoven. The case is styled Interwoven, Inc. v Vertical Computer Systems, Inc., No. 3:10-CV-4645-RS.
On January 11, 2011, Samsung Electronics Co., Ltd. and Samsung Electronics America, Inc. (“Samsung”) filed a lawsuit in the United States District Court for the Northern District of California seeking to consolidate its lawsuit with the Interwoven Action. This case is styled Samsung Electronics Co., Ltd. and Samsung Electronics America, Inc., v. Vertical Computer Systems, Inc., No. 3:11-CV-00189-RS.
On May 2, 2011, the United States District Court for the Northern District of California denied Vertical’s renewed motion to transfer the Interwoven Action to the Eastern District of Texas and granted Vertical's motion to transfer the lawsuit filed by Samsung in the Northern District of California to the Eastern district in Texas. On May 11, 2011, the United States District Court for the Eastern District of Texas granted Interwoven’s motions to transfer the case to the Northern District of California with respect to Interwoven and denied Samsung’s motion to transfer its case to the Northern district. On May 12, 2011, Vertical filed in the United States Court of Appeals for the Federal Circuit a petition for a writ of mandamus seeking review of that portion of the May 2, 2011 order by the Northern District of California which refused to transfer the Interwoven v. Vertical action to the Eastern District of Texas.
In the opinion of management, the ultimate resolution of any pending matters may have a significant effect on our financial position, operations or cash flows. Also, in the future, we may become involved in other legal actions that may have a significant effect on our financial position, operations or cash flows.
Item 1A. Risk Factors
A description of the risks associated with our business, financial condition, and results of operations is set forth on Form 10-K for the year ended December 31, 2010, as filed on April 15, 2011.
I don't post much on this board but I read it daily. IMO you are a decent and level headed individual and there are some here who could take a page from your book
it will be interesting to see what happens if LVLT drops to $1.25.
In particular whether or not FBR changes their rating to a buy and what kind of volume increase or decrease we get
Equities research analysts at Zacks Investment Research reiterated a “neutral” rating on shares of Altair Nanotechnologies, Inc. (NASDAQ: ALTI) in a research note to investors on Thursday.
Separately, analysts at MDB Research upgraded shares of Altair Nanotechnologies, Inc. to a “buy” rating in a research note to investors on Wednesday, March 2nd. They now have a $3.50 price target on the stock, up previously from $3.20.
Shares of Altair Nanotechnologies, Inc. traded flat at $1.42 during mid-day trading on Friday. Altair Nanotechnologies, Inc. has a 52 week low of $1.20 and a 52 week high of $3.32. The stock’s 50-day moving average is $1.83 and its 200-day moving average is $2.32. The company has a market cap of $38.4 million.
Altair Nanotechnologies Inc. is engaged in the business of developing, manufacturing and selling its nano lithium titanate battery products and providing related design, installation and test services. The Company’s primary focus is marketing its large-scale energy storage solutions to power companies and electric grid operators throughout the world. In addition, it also markets its battery products to the electric and hybrid-electric mass-transit markets. It also provides contract research services on select projects where it can utilize its resources to develop intellectual property and/or new products and technology. The Company is organized into two divisions: Power and Energy Group and all other division.
For more information about Zacks Investment Research‘s equity research offerings, visit Zacks.com.
Posted April 24, 2011
Connection to Level 3 Backbone Enables Verizon Wireless to Adapt and Stay Ahead of Exploding Demand for Mobile Data
BROOMFIELD, Colo.--(BUSINESS WIRE)-- Level 3 Communications, Inc. (NASDAQ: LVLT) today announced that it is providing Verizon Wireless with backbone infrastructure and cell-site backhaul solutions to support its ongoing rollout of its 4G Long Term Evolution (LTE) network.
Driven by the proliferation of rich applications and video on smartphones, tablets, laptops and e-readers, Verizon Wireless will rely on Level 3’s nationwide fiber-optic network and responsive team to meet the growing demand for mobile data. Level 3 helps Verizon Wireless build the network headroom and redundancy needed to accommodate the projected network growth tied to its 4G LTE network rollout.
“Customers’ demand for mobile data is growing exponentially, and we are expanding the reach of our 4G LTE network to ensure we meet that need,” said Verizon Wireless Network Vice President Nicki Palmer. “Level 3’s technology will help us provide our 4G LTE customers with a mobile experience that is fast, reliable and rich with content.”
Level 3 is also supporting cell-site backhaul requirements in a number of rural markets in New England and the Western United States for Verizon Wireless by leveraging its recently launched Tower Access solution that combines connectivity to existing cell towers with a mix of new on-site tower construction and colocation at Level 3 sites.
“Wireless consumers and enterprise users demand the ability to be connected to everything, everywhere, all the time – something we’ve been ready to handle for years,” said Andrew Crouch, president of Sales for Level 3. “Starting over a decade ago, we designed a network from the ground up to handle evolving and growing data needs. Verizon Wireless is leveraging our technologies to build one of the world’s most advanced wireless networks.”
Verizon Wireless is a global leader in 4G LTE deployment. Verizon Wireless expects 4G LTE average data rates to be 5 to 12 megabits per second (Mbps) on the downlink and 2 to 5 Mbps on the uplink in real-world, loaded network environments. These speeds are significantly faster than current or promised 3G network speeds. To date, Verizon Wireless has announced that consumer and business customers in at least 147 U.S. cities will have access to the fastest, most advanced 4G mobile network in America by the end of 2011.
Level 3’s scalable, continuously upgradable network supports today’s applications and lays the foundation for tomorrow’s IP-centric wireless infrastructures. For more information on Level 3’s advanced network and service offerings, visit www.level3.com.
Read more: Level 3 Helps Power Verizon Wireless 4G LTE Network Rollout - FierceTelecom http://www.fiercetelecom.com/press_releases/level-3-helps-power-verizon-wireless-4g-lte-network-rollout-0#ixzz1KSDPlBSE
Subscribe: http://www.fiercetelecom.com/signup?sourceform=Viral-Tynt-FierceTelecom-FierceTelecom
http://www.zacks.com/research/get_news.php?id=110l7265
TRADERS GOBBLING UP SHARES OF LEVEL 3 COMMUNICATIONS, SHARES UP 2.5% (LVLT)Print Share Apr 20, 2011 (SmarTrend(R) Spotlight via COMTEX) -- Level 3 Communications (NASDAQ:LVLT) is one of today's best performing low-priced stocks, up 2.5% to $1.66 on 0.1x average daily volume. Approximately 3.3 million shares have traded hands today vs. 30-day average volume of 31.2 million shares.
High volume often signals a change in trends. Shares of Level 3 Communications are currently trading above their 50-day moving average (MA) of $1.41 and above their 200-day MA of $1.14.
SmarTrend scans for speculative low-price stocks under $5 for reversals in trends. A large price movement may signal continuation or reversal of a trend.
Level 3 Communications is in SmarTrend's Telecom Services- Domestic industry and this industry is currently in an Uptrend. An industry trend that matches the stock's trend helps to add conviction to the stock's Uptrend and price prediction.
SmarTrend currently has shares of Level 3 Communications in an Uptrend and issued the Uptrend alert on November 09, 2010 at $1.04. The stock has risen 55% since the Uptrend alert was issued.
Write to Chip Brian at cbrian@mysmartrend.com
April 19 2011 Share1 inShareEmail This
Today's Trending Stocks
Click a Company to Research Now:
According to analyst Michael Pachter at Wedbush Morgan, Netflix (NASDAQ:NFLX) is going to beat consensus earnings estimates Monday April 25.
Here’s Pachter’s bullet points for his preview of Netflix earnings:
Netflix will report its Q1 2011 (March) results after market close on Monday, April 25 with a call at 3:00pm PT (http://ir.netflix.com).
We expect Q1 results in-line with our estimates for revenue of $715 million, ending subs of 23.7 million, and EPS of $1.13, compared with consensus for revenue of $704 million and EPS of $1.07.
Continued subscriber growth remains key to achieving top-line guidance. Webelieve Netflix will offset declining ARPU through its very popular $7.99/month streaming-only plans, and increasing penetration of video game consoles and CE devices. Netflix should also benefit from Blockbuster’s proposed sale to Dish Network. Dish is expected to liquidate Blockbuster’s assets, with customers moving to Redbox and Netflix, particularly Blockbuster’s ~1 million By Mail customers.
Netflix (NASDAQ:NFLX) is unlikely to provide detailed FY:11 guidance. In our view, Netflix’s reticence to provide detailed guidance reflects its unwillingness to provide visibility into the cost of new content deals. We think that the cost of these deals is rising rapidly, far outpacing postage and DVD savings, and think earnings growth, while impressive, will be far slower than the current share price implies.
We expect streaming content costs to increase by at least $500 million in 2011. In this note, we have estimated the cost of each current streaming content deal, and estimate that the cost of these deals has risen from around $180 million in 2010 to a likely case of $1.975 billion in 2012. Netflix (NASDAQ:NFLX) has not confirmed financial terms of studio deals, but it is clear that streaming costs will rise significantly in the near future (although likely after Q1:11), more than offsetting declining fulfillment, marketing, DVD purchase and postage expenses.
Maintaining our UNDERPERFORM rating and our 12-month price target of $80, which reflects 20x our FY:11 EPS estimate of $4.00. This multiple is at Netflix’s (NASDAQ:NFLX) expected long-term earnings growth rate to reflect positive execution.
Based on these views, we recommend reviewing shares of content distribution networks Level 3 Communications (NASDAQ:LVLT)
NOT GOOD NEWS
RENO, NV--(Marketwire - April 15, 2011) - Altair Nanotechnologies, Inc. (Altairnano) (NASDAQ: ALTI), today announced that it received notification from Inversiones Energéticas, S.A. de C.V. (INE), that it was exercising its right to terminate the contract signed in February 2011 for the 10 Megawatt ALTI-ESS advanced battery system for frequency control. According to the termination letter, INE's action was based upon notice it recently received from SIGET, the government entity that regulates the electric utility market in El Salvador. SIGET stated that the application of this new technology is not feasible in the short term as no procedures exist in the policies of the wholesale electricity market in El Salvador that regulate the operation of systems like the ALTI-ESS.
It was anticipated by both INE and Altairnano that the appropriate regulatory procedures and policies would be put into place within the timeframes contemplated and that the issuance of the notice to proceed would occur within a reasonably short time after formalizing the contract. "We are extremely disappointed by this unexpected setback," stated Dr. Terry Copeland President and CEO of Altairnano, "but we will continue to work diligently with the management of INE to address this latest obstacle and bring the benefits of this excellent technology to the El Salvador electric grid."
RELAVELY HIGH UPSIDE POTENTIAL DETECTED IN SHARES OF ALTAIR NANOTECHNOLOGIES IN THE SPECIALTY CHEMICALS INDUSTRY (ALTI, ADES, LNDC, SNMX, OMN)Print Share Apr 15, 2011 (SmarTrend(R) News Watch via COMTEX) -- Below are the top five companies in the Specialty Chemicals industry as measured by the potential gains between the current stock price and the projected average analyst target.
Altair Nanotechnologies (NASDAQ:ALTI) has a potential upside of 124.4% based on a current price of $1.56 and an average consensus analyst price target of $3.5.
http://www.zacks.com/research/get_news.php?id=095l7656
HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings EPS Surprises Mutual Funds Options My Account Help
Zacks #1 Rank
Our founder Len Zacks uncovered the powerful relationship between earnings estimate revisions and stock price. He carefully crafted that discovery into a ranking system that averages +28% per year. Click Here to Learn More.
Quote: Search for Ticker
Login User Name: Password:
Remember me [?] Forgot Password New Member
Free Membership Search:
Sponsored Links
TRADERS GOBBLING UP SHARES OF LEVEL 3 COMMUNICATIONS, SHARES UP 2.1% (LVLT)Print Share Apr 05, 2011 (SmarTrend(R) Spotlight via COMTEX) -- Level 3 Communications (NASDAQ:LVLT) is one of today's best performing low-priced stocks, up 2.1% to $1.45 on 0.4x average daily volume. Approximately 6.6 million shares have traded hands today vs. 30-day average volume of 17.4 million shares.
High volume often signals a change in trends. Shares of Level 3 Communications are currently trading above their 50-day moving average (MA) of $1.33 and above their 200-day MA of $1.11.
SmarTrend scans for speculative low-price stocks under $5 for reversals in trends. A large price movement may signal continuation or reversal of a trend.
Level 3 Communications is in SmarTrend's Telecom Services- Domestic industry and this industry is currently in an Uptrend. An industry trend that matches the stock's trend helps to add conviction to the stock's Uptrend and price prediction.
SmarTrend currently has shares of Level 3 Communications in an Uptrend and issued the Uptrend alert on November 09, 2010 at $1.04. The stock has risen 35.9% since the Uptrend alert was issued.
Write to Chip Brian at cbrian@mysmartrend.com
thanks, I think that needed to be said
I would like to believe so. Some positive clinical news would surely propel us forward beyond 5
Equities research analysts at Needham & Company initiated coverage on shares of Pluristem Therapeutics (NASDAQ: PSTI) in a research note to investors on Monday. The analysts set a “buy” rating and a $5.00 price target on the stock.
Separately, analysts at WBB Securities initiated coverage on shares of Pluristem Therapeutics in a research note to investors on Tuesday, March 1st. They set a “buy” rating and a $4.00 price target on the stock. Also, analysts at National Securities initiated coverage on shares of Pluristem Therapeutics in a research note to investors on Monday, January 10th. They set a “buy” rating on the stock.
Shares of Pluristem Therapeutics opened at 2.96 on Tuesday. Pluristem Therapeutics has a 52 week low of $0.94 and a 52 week high of $4.38. The stock’s 50-day moving average is $2.51 and its 200-day moving average is $1.99. The company has a market cap of $122.3 million.
Pluristem Therapeutics Inc. (Pluristem) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived from human placenta, a non-controversial, non-embryonic, adult stromal cell source. The placental adherent stromal cells (ASCs) are grown in the Company’s PluriX three-dimensional (3-D) bioreactor, which imitates the natural microstructure of the body. It is focusing on clinical indication that the route of administration is intramuscular. This route of administration applicable for several different indications, such as Peripheral artery disease (PAD), Critical limb ischemia (CLI), intermittent claudication, neuropathic pain, wound healing and orthopedic injuries.
http://www.americanbankingnews.com/2011/04/05/needham-company-analysts-begin-coverage-on-pluristem-therapeutics-psti/
http://www.istockanalyst.com/business/news/5032041/roundup-israeli-bio-tech-firm-touts-stem-cell-treatment-formultiple-sclerosis
JERUSALEM, Apr. 4, 2011 (Xinhua News Agency) -- Haifa-based Pluristem Therapeutics (NASDAQ:PSTI) has announced that their patented technique for harvesting and growing stem cells from human placenta can successfully treat a wide variety of illnesses, among them multiple sclerosis and diabetes.
Stem cells are "primitive" cells that have the unique ability to develop into any type of cell in the body, allowing for therapeutic treatment of a variety of illnesses. There are two types: embryonic stem cells derived from pre-implantation embryos, and adult adherent stromal cells (ASCs), which can be used in tissue replacement and repair. By using placental cells, Pluristem says they avoid ethical issues surrounding the use of embryonic stem cells.
"We combine a unique source of stem cells, with a unique 3-D manufacturing technique that was developed by the Weizmann ( Institute of Science in Rehovot, Israel) and the (Haifa) Technion Israel Institute of Technology," Pluristem CEO Zami Aberman told Xinhua on Sunday.
"Combining them together gave us a platform that can be used for a variety of indications," Aberman said, referring to a range of maladies that the stem cells, grown from ASCs, can treat.
ASCs can grow into a number of different cells, such as nerve, bone marrow, cartilage, ligament, fat, muscle, and tendon cells, and are potentially able to replace damaged tissue.
The company says its range of PLacental eXpanded (PLX) cells can be used in the treatment of hematological diseases, including Peripheral Arterial Disease (PAD) and blood cancer, in bone marrow transplants, in central nervous system diseases, including multiple sclerosis and Ischemic stroke, and gastrointestinal disorders, such as Crohn's Disease.
In a proprietary process, placental-derived cells are harvested and grown in a patented chemical-free process in a bio-reactor, and then prepared and frozen until use.
Through an infusion, the cells, which do not require tissue matching or immune-suppression treatment, migrate to the afflicted area where they secrete disease-specific proteins, according to the firm.
"We injected 27 patients...and there was no reaction against our cells," Aberman pointed out.
Aberman says their development is commonly used in treating PAD, which is caused by heavy smoking, diabetes, alcoholism, and obesity, in which plaque gradually constricts, and then clogs and blocks arteries. In the lower extremities, the deteriorating arterial flow can lead to pain, wounds, and in extreme cases, amputation.
"We use the 'PLacental eXpanded (PLX)' cells, which are injected into the affected limb in order to eliminate the amputation," Aberman explained.
In March, the firm announced a partnership to begin clinical trials of the cell to treat diabetic foot ulcers at New York University. The American Centers for Disease Control reports that some 12 percent or 2.5 million patients in the United States suffering from diabetes, develop a foot ulcer.
Additionally, "we recently announced our entry into treating muscle injury," with the Charite-University of Medicine at the Berlin-Brandenburg Center for Regenerative Therapies in Germany, Aberman said, which the firm believes can potentially open up a 10 billion U.S. dollar annual market.
"We plan to have about 20 centers in Europe and another 20 in the U.S.," Aberman said.
As well, "we're the only stem cell company that's been approved for clinical studies by the European Commission and the American Food and Drug administration," Aberman said.
Additionally, international pharma giant, Roche announced earlier this week that they are establishing a stem cell consortium to be based on intellectual property rights of Israeli stem cell researchers at The Hebrew University of Jerusalem and the Technion, according to the Globes business daily.
Commenting on the step, Pluristem's CFO and VP Yaky Yanay on Monday said the move "serves as a proof-point for Israel's strong track record for developing innovative technologies as well as a validation of the hard work put in by the scientists and R&D teams developing these technologies."
"Israel's growing stem cell industry is known throughout the world for commercializing cutting edge technologies and the establishment of this consortium is sure to lead to additional and substantial breakthroughs," Yanay told Xinhua.
Pluristem firm hopes to see the technology marketed by 2014.
AT last a voice of reason in a sea noise
like I said board censors
BUGS is the millstone around greenmountain's neck. It will never go anywhere as long as this stock goes nowhere!
All new investor's will always see how Brehm dealt with BUGS, and that wil be their signpost as to how he will ultimately deal with them
I think it has to do with the news associated with the note 3/29/2011. pertaining to uncertainties with Canon LTD and issuance of warrants
Altair Nanotechnologies, Inc. (Nasdaq: ALTI) 25.2% LOWER; has entered into several agreements for the private placement for $6.4 million of common stock. Under the terms of the transaction, these institutional investors will purchase 3.6 million shares of Altair common stock at a purchase price of $1.784 per share.
http://www.streetinsider.com/Special+Reports/Morning+Movers+0329%3A+(TRCI)+(SHZ)+Higher%3B+(HRZ)+(ALTI)+(DYP)+(NVGN)+(ACMR)+Lower/6393705.html
Level 3 Communications (NASDAQ:LVLT) follows with an RPE of $0.7M
rpe is revenue per employee
http://www.zacks.com/research/get_news.php?id=088l2495
Superconductor Technologies, Inc. (NASDAQ:SCON) is the 3rd best-performing stock year-to-date in this segment of the market. It has risen 84.21% since the beginning of this year. Its price percentage change is -6.04% for the last 52 weeks.
http://www.cnanalyst.com/2011/03/top-10-best-performing-telecom-equipment-stocks-year-to-date-inph-clro-scon-xeta-alu-pwav-arun-exfo-.html
Mar 29, 2011 08:00 ETAltair Nanotechnologies Inc. Announces Common Stock and Warrant Offering
RENO, NV--(Marketwire - March 29, 2011) - Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced it has entered into definitive agreements with select institutional investors to raise gross proceeds of approximately $6.4 million, before deducting placement agent's fees and other offering expenses, in a registered direct offering. Altair intends to use the proceeds from the offering for general corporate purposes and working capital to execute the recently announced customer contracts. Under the terms of the transaction, these institutional investors will purchase 3.6 million shares of Altair common stock at a purchase price of $1.784 per share. In addition, if for any reason the Canon transaction previously announced does not close, the company will issue to the investors up to an additional 1.8 million shares. Investors will also receive warrants to purchase one share of common stock for every 2.0 shares of common stock purchased. The warrants will be exercisable at any time beginning six months after the date of issuance for a period of five years at an exercise price of $2.56 per share of common stock. The closing of the offering is expected to take place on March 30, 2011, subject to the satisfaction of customary closing conditions. JMP Securities LLC acted as the exclusive placement agent for the transaction.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The shares of common stock and warrants described above are being offered pursuant to registration statement previously declared effective by the Securities and Exchange Commission and a prospectus, forming a part of the effective registration statement. Copies of the final prospectus supplement for this offering and accompanying base prospectus may be obtained at the Securities and Exchange Commission web site at http://www.sec.gov, or from JMP Securities LLC, 600 Montgomery Street, Suite 600, San Francisco, CA 94111.
LOL.. the next thing you know you will have a picture of the 2 of them on the stern of the SATORI fishing
Yeh, we almost hit the .07 mark again the other day. This is slowly developing into an interesting play
thank you
I tried to google Ark Capital Ventures and found a facade of a web site can you confirm that they are a legitimate company.
i.e. are they a real.
This is a simple question it is not a bashing. Can anyone confirm this. This is an issue for the moderators. They are in contact with the company
I am sorry that I have not read all of the post, but has anyone been able to confirm the existence of Ark Capital Ventures? When I google them all I get is a Potemkin village of a web site
all of your point are legitimate and deserve to be addressed in an honest and forthright manner
you are right the dtc are one or less. so the likelihood of a short squeeze is small. however I have never seen anyone shorting a stock in expectation of rising share price